Limits...
Hyaluronic acid as a treatment for ankle osteoarthritis.

Sun SF, Chou YJ, Hsu CW, Chen WL - Curr Rev Musculoskelet Med (2009)

Bottom Line: It is currently indicated only for the treatment of pain associated with knee OA.Ankle OA produces chronic disability that directly impacts the quality of life.There is only limited published literature relating to the use of HA in the ankle.

View Article: PubMed Central - PubMed

Affiliation: Department of Physical Medicine and Rehabilitation, Veterans General Hospital, Kaohsiung, No 386, Ta-Chung 1st Road, Kaohsiung 813, Taiwan. sfsun.tw@yahoo.com.tw

ABSTRACT
Viscosupplementation refers to the concept of synovial fluid replacement with intra-articular injections of hyaluronic acid (HA) for the relief of pain associated with osteoarthritis (OA). Intra-articular viscosupplementation was approved by the Food and Drug Administration (FDA) in 1997. It is currently indicated only for the treatment of pain associated with knee OA. However, OA can occur in several of the weight-bearing joints of the foot and ankle. Ankle OA produces chronic disability that directly impacts the quality of life. There is only limited published literature relating to the use of HA in the ankle. This paper will review the authors' experience, indications, clinical outcomes, and complications of viscosupplementation therapy in patients with ankle OA.

No MeSH data available.


Related in: MedlinePlus

Ankle joint injection
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2697335&req=5

Fig1: Ankle joint injection

Mentions: We position the patient in the supine position, with the knee flexed and the foot flat on the plinth. The ankle is placed in a degree of plantarflexion, which opens the anterior aspect of the joint. We identify the space between the anterior border of the medial malleolus and the medial border of the tibialis anterior tendon and palpate this space for the articulation of the talus and tibia to locate a suitable entry point into the ankle joint. An alternative point of entry may also be made at the upper, inner aspect of either malleolus. The injections are performed in aseptic conditions. We insert an 18–22 G needle into the identified space and direct posterolaterally to run parallel to the upper surface of the talus, which is slightly convex (Figs. 1 and 2). Joint effusion, if present, should be aspirated before injection to prevent dilution of the viscosupplement. Excessive weight bearing and strenuous activity are discouraged for 48 h after each injection.Fig. 1


Hyaluronic acid as a treatment for ankle osteoarthritis.

Sun SF, Chou YJ, Hsu CW, Chen WL - Curr Rev Musculoskelet Med (2009)

Ankle joint injection
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2697335&req=5

Fig1: Ankle joint injection
Mentions: We position the patient in the supine position, with the knee flexed and the foot flat on the plinth. The ankle is placed in a degree of plantarflexion, which opens the anterior aspect of the joint. We identify the space between the anterior border of the medial malleolus and the medial border of the tibialis anterior tendon and palpate this space for the articulation of the talus and tibia to locate a suitable entry point into the ankle joint. An alternative point of entry may also be made at the upper, inner aspect of either malleolus. The injections are performed in aseptic conditions. We insert an 18–22 G needle into the identified space and direct posterolaterally to run parallel to the upper surface of the talus, which is slightly convex (Figs. 1 and 2). Joint effusion, if present, should be aspirated before injection to prevent dilution of the viscosupplement. Excessive weight bearing and strenuous activity are discouraged for 48 h after each injection.Fig. 1

Bottom Line: It is currently indicated only for the treatment of pain associated with knee OA.Ankle OA produces chronic disability that directly impacts the quality of life.There is only limited published literature relating to the use of HA in the ankle.

View Article: PubMed Central - PubMed

Affiliation: Department of Physical Medicine and Rehabilitation, Veterans General Hospital, Kaohsiung, No 386, Ta-Chung 1st Road, Kaohsiung 813, Taiwan. sfsun.tw@yahoo.com.tw

ABSTRACT
Viscosupplementation refers to the concept of synovial fluid replacement with intra-articular injections of hyaluronic acid (HA) for the relief of pain associated with osteoarthritis (OA). Intra-articular viscosupplementation was approved by the Food and Drug Administration (FDA) in 1997. It is currently indicated only for the treatment of pain associated with knee OA. However, OA can occur in several of the weight-bearing joints of the foot and ankle. Ankle OA produces chronic disability that directly impacts the quality of life. There is only limited published literature relating to the use of HA in the ankle. This paper will review the authors' experience, indications, clinical outcomes, and complications of viscosupplementation therapy in patients with ankle OA.

No MeSH data available.


Related in: MedlinePlus